COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

30,236 Articles (22,227 medRxiv, 8,009 bioRxiv)

Most recent first Previous |  Page 2602: Articles 26011-26020  | Next

Syndromic Surveillance for COVID-19 in Canada
Lapointe-Shaw, L., Rader, B., Astley, C. M., Hawkins, J. B., Bhatia, D., Schatten, W. J., Lee, T. C., Liu, J. J., Ivers, N. M., Stall, N. M., Gournis, E., Tuite, A. R., Fisman, D. N., Bogoch, I. I., Brownstein, J. S.
10.1101/2020.05.19.20107391 — Posted: 2020-05-26
Impaired T cell functions along with elevated activated Tregs at the early stage of asymptomatic SARS-CoV-2 infection
Yang, J., Zhang, E., Zhong, M., Yang, Q., Hong, K., Shu, T., Zhou, D., Xiang, J., Xia, J., Zhou, X., Zhang, D., Huang, C., Shang, Y., Yan, H.
10.1101/2020.05.25.20108852 — Posted: 2020-05-26 Discussion: Onsite | Offsite
A benchmark of online COVID-19 symptom checkers
Munsch, N., Martin, A., Gruarin, S., Nateqi, J., Abdarahmane, I., Weingartner-Ortner, R., Knapp, B.
10.1101/2020.05.22.20109777 — Posted: 2020-05-26
Use of High Flow Nasal Therapy to Treat Moderate to Severe Hypoxemic Respiratory Failure in COVID-19
Patel, M., Gangemi, A., Marron, R., Chowdhury, J., Yousef, I., Zheng, M., Mills, N., Tragesser, L., Giurintano, J., Gupta, R., Gordon, M., Rali, P., D'Alonzo, G., Fleece, D., Zhao, H., Patlakh, N., Criner, G. J.
10.1101/2020.05.22.20109355 — Posted: 2020-05-26
Assessment of small pulmonary blood vessels in COVID-19 patients using HRCT
Lins, M., Vandevenne, J., Thillai, M., Lavon, B. R., Lanclus, M., Bonte, S., Godon, R., De Backer, J., De Backer, W.
10.1101/2020.05.22.20108084 — Posted: 2020-05-26
COVID-19 in Bangladesh: Measuring differences in individual precautionary behaviors among young adults
Imtiaz, A., Hossain, M. A., Khan, N. M.
10.1101/2020.05.21.20108704 — Posted: 2020-05-26
Currently prescribed drugs in the UK that could up or downregulate ACE2 in COVID-19 disease: A systematic review
Dambha-Miller, H., Albasri, A., Hodgson, S., Wilcox, C. R., Khan, S., Nazrul Islam, N., Little, P., Griffin, S. J.
10.1101/2020.05.19.20106856 — Posted: 2020-05-26
Identification of severity zones for mitigation strategy assessment COVID-19 outbreak in Malaysia
Ahmad, T., Ashaari, A., Awang, S. R., Mamat, S. S., Wan Mohamad, W. M., Ahmad Fuad, A. A., Hassan, N.
10.1101/2020.05.19.20107359 — Posted: 2020-05-26
Expanding Covid-19 Testing: Mathematical Guidelines for the Optimal Sample Pool Size Given Positive Test Rate
Adams, K.
10.1101/2020.05.21.20108522 — Posted: 2020-05-26
Computational Simulation to Assess Patient Safety of Uncompensated COVID-19 Two-patient Ventilator Sharing Using the Pulse Physiology Engine
Webb, J. B., Bray, A., Asare, P. K., Clipp, R. B., Mehta, Y. B., Penupolu, S., Patel, A. A., Poler, S. M.
10.1101/2020.05.19.20107201 — Posted: 2020-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).